Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates
Sophie Jones(FIND), Teun Bousema(Radboud University Nijmegen), Michael Theisen(Statens Serum Institut), Jaffu Chilongola(Kilimanjaro Christian Medical Centre), Chris Drakeley(London School of Hygiene & Tropical Medicine), Lynn Grignard(London School of Hygiene & Tropical Medicine), Kevin K. A. Tetteh(London School of Hygiene & Tropical Medicine), Issa Nébié(Centre National de Recherche et de Formation sur le Paludisme), Eric Kyei‐Baafour(University of Ghana), Robert W. Sauerwein(TropIQ Health Sciences), Rajesh Kumar Singh(Emcure Pharmaceuticals (India)), Shrawan Singh, Daniel Dodoo(Commonwealth Scientific and Industrial Research Organisation), Will Roeffen(Radboud University Nijmegen), Sanjay Singh
Cited by 67
Related Papers
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591
Genome-wide and fine-resolution association analysis of malaria in West Africa
|Nature Genetics|2009|393
Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination
|PLoS Medicine|2013|356
<i>Plasmodium falciparum</i> Associated with Severe Childhood Malaria Preferentially Expresses PfEMP1 Encoded by Group A <i>var</i> Genes
|The Journal of Experimental Medicine|2004|332
Absolute Levels and Ratios of Proinflammatory and Anti‐inflammatory Cytokine Production In Vitro Predict Clinical Immunity to<i>Plasmodium falciparum</i>Malaria
|The Journal of Infectious Diseases|2002|245